Celebrex May Reduce Skin Cancer

A twice-daily dose of  Celebrex over a period of nine months reduced the incidence of nonmelanoma skin cancer by almost 60 percent, according a new study. Read on..SID: COX-2 Inhibitors May Cut Skin Cancer Rate

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

Other Articles You May Be Interested In...

Post a Comment

You must be logged in to post a comment.